Point72 Asia »

Black Diamond Therapeutics shares owned by Point72 Asia

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Point72 Asia from 13F filings

Historical chart of Point72 Asia investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Point72 Asia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Point72 Asia

Quarter filed Position value Share count Share price at filing
2025-09-30 $78k 21k 3.79
2025-06-30 $44k 18k 2.48
2024-03-31 $188k 37k 5.07

More positions owned by Point72 Asia

Cyberark Software SHS (CYBR)
Kellogg Company (K)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Norfolk Southern (NSC)
Seagate Technology Hldngs Pl Ord Shs (STX)
Chart Industries (GTLS)
Ceridian Hcm Hldg (DAY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Frontier Communications Pare (FYBR)
Alphabet Cap Stk Cl A (GOOGL)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Applied Optoelectronics (AAOI)

View all positions for Point72 Asia

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
NEA Management Company
Vanguard Group
Tang Capital Management
Marshall Wace
Siren
BlackRock
Arrowstreet Capital, Limited Partnership
Millennium Management
UBS Group
AWM Investment Company
Renaissance Technologies
Geode Capital Management
Northern Trust

View all funds holding Black Diamond Therapeutics